Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults

NCT01046539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

Substance-Related Disorders

Interventions

DRUG: RDC-0313 + Buprenorphine
DRUG: Placebo

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]